Greenline Partners, LLC Pfizer Inc Transaction History

Greenline Partners, LLC

$733 Million
Q2 2025

A detailed history of Greenline Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Greenline Partners, LLC holds 54,647 shares of PFE stock, worth $1.35 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

54,647

Previous 55,318 1.21%

Holding current value

$1.35 Million

Previous $1.4 Million 5.5%

% of portfolio

0.18%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$21.59 - $24.84 $14,486 - $16,667	-671 Reduced 1.21%	54,647 $1.32 Million
Q1 2025 May 15, 2025	SELL	$25.01 - $27.13 $191,726 - $207,978	-7,666 Reduced 12.17%	55,318 $1.4 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $56,978 - $64,569	-2,057 Reduced 3.16%	62,984 $1.82 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $112,684 - $132,045	-4,461 Reduced 6.42%	65,041 $1.82 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $18,148 - $20,840	-701 Reduced 1.0%	69,502 $1.93 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $358,085 - $465,113	-13,704 Reduced 16.33%	70,203 $2.02 Million
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $89,274 - $104,352	-2,782 Reduced 3.21%	83,907 $2.78 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $98,715 - $114,212	-2,733 Reduced 3.06%	86,689 $3.18 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $221,489 - $288,347	-5,623 Reduced 5.92%	89,422 $3.65 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1.65 Million - $2.16 Million	-39,552 Reduced 29.39%	95,045 $4.87 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $1.79 Million - $2.19 Million	-40,908 Reduced 23.31%	134,597 $5.89 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $249,912 - $296,318	5,371 Added 3.16%	175,505 $9.2 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $65,148 - $80,726	-1,424 Reduced 0.83%	170,134 $8.81 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $286,760 - $425,075	6,940 Added 4.22%	171,558 $10.1 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $667 - $857	17 Added 0.01%	164,618 $7.08 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $61,944 - $70,173	-1,725 Reduced 1.04%	164,601 $6.45 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $602,250 - $679,217	17,983 Added 12.12%	166,326 $6.03 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $2,209 - $2,808	-66 Reduced 0.04%	148,343 $5.46 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $2.47 Million - $2.9 Million	77,924 Added 110.55%	148,409 $5.45 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $15,692 - $19,037	-521 Reduced 0.73%	70,485 $2.3 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $1.14 Million - $1.62 Million	-42,043 Reduced 37.19%	71,006 $2.32 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $368,704 - $418,432	-11,200 Reduced 9.01%	113,049 $4.43 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $249,718 - $323,811	7,686 Added 6.59%	124,249 $4.46 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $23,963 - $26,904	648 Added 0.56%	116,563 $5.05 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $4.46 Million - $4.9 Million	-118,867 Reduced 50.63%	115,915 $4.92 Million
Q3 2018 Oct 15, 2018	SELL	$34.47 - $41.81 $57,875 - $70,198	-1,679 Reduced 0.71%	234,782 $10.3 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $176,179 - $187,824	-5,342 Reduced 2.21%	236,461 $8.58 Million
Q1 2018 Jun 21, 2018	BUY	$31.91 - $37.02 $636,253 - $738,141	19,939 Added 8.99%	241,803 $8.58 Million
Q4 2017 Jun 21, 2018	BUY	$33.26 - $35.29 $7.38 Million - $7.83 Million	221,864	221,864 $8.04 Million

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenline Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenline Partners, LLC with notifications on news.

Account

Greenline Partners, LLC Pfizer Inc Transaction History